Royalty Pharma Plc (RPRX)
50.00
+1.52
(+3.14%)
USD |
NASDAQ |
Apr 17, 16:00
50.00
0.00 (0.00%)
After-Hours: 05:13
Royalty Pharma SG&A Expense (Quarterly) : 164.00M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Zymeworks, Inc. | 15.43M |
| Johnson & Johnson | 0.00 |
| Revolution Medicines, Inc. | 66.68M |
| Corcept Therapeutics, Inc. | 130.24M |
| Cytokinetics, Inc. | 91.72M |